Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01015976 · ClinicalTrials.gov registry record · Phase 3
A Preliminary Comparison of the Blood Levels of Medications in Obese Subjects Compared to Post-Gastric Bypass Subjects
A Phase 3 study, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
- Completed
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT01015976 is a Phase 3 study that has completed, run by Neuropsychiatric Research Institute, Fargo, North Dakota. The registered enrollment target is 10 participants.
The verdict
NCT01015976, a Phase 3 study, has completed, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the difference, if any, in the area under the sertraline plasma level time curve (AUC) between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
Interventions
- OTHER control
- PROCEDURE bariatric surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01015976
The ClinicalTrials.gov registry entry for NCT01015976 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuropsychiatric Research Institute, Fargo, North Dakota, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which control is the first listed.
NCT01015976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01015976 about?
NCT01015976 is a clinical study titled "A Preliminary Comparison of the Blood Levels of Medications in Obese Subjects Compared to Post-Gastric Bypass Subjects". The purpose of this study is to determine the difference, if any, in the area under the sertraline plasma level time curve (AUC) between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
What is the current status of trial NCT01015976?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2009-02. Estimated completion is 2010-04.
What interventions are being tested in trial NCT01015976?
The interventions under investigation include: control (OTHER), bariatric surgery (PROCEDURE).
Who is sponsoring clinical trial NCT01015976?
This trial is sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.